On Sept. 23, the U.S. Food and Drug Administration (FDA) approved revised labeling for the Sapien Transcatheter Heart Valve (THV), making the device available to patients who have inoperable aortic valve stenosis. Read More.

FDA expands access to artificial heart valve to inoperable patients
Author(s):
By: